Attached files
| file | filename |
|---|---|
| 10-Q - IDENIX PHARMACEUTICALS INC | v162847_10q.htm |
| EX-31.2 - IDENIX PHARMACEUTICALS INC | v162847_ex31-2.htm |
| EX-10.1 - IDENIX PHARMACEUTICALS INC | v162847_ex10-1.htm |
| EX-32.1 - IDENIX PHARMACEUTICALS INC | v162847_ex32-1.htm |
| EX-31.1 - IDENIX PHARMACEUTICALS INC | v162847_ex31-1.htm |
| EX-10.2 - IDENIX PHARMACEUTICALS INC | v162847_ex10-2.htm |
EXHIBIT
32.2
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Quarterly Report on Form 10-Q of Idenix Pharmaceuticals,
Inc. (the “Company”) for the quarter ended September 30, 2009 as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), the
undersigned, Ronald C. Renaud, Jr., Chief Financial Officer of the Company,
hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted by
Section 906 of the Sarbanes-Oxley Act of 2002, that, to his
knowledge:
|
(1)
|
The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
the
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
October 29, 2009
|
/s/
RONALD C. RENAUD, JR.
|
|||
|
Ronald
C. Renaud, Jr.
|
|||
|
Chief
Financial Officer
|
A
signed original of this written statement required by Section 906 has been
provided to Idenix Pharmaceuticals, Inc. and will be retained by Idenix
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.